REQUEST A QUOTE

Submit
CFLIVER PATHOLOGYDONOR AGE / GENDERDONOR MORBIDITIESNORMAL
(GRADE 0 STEATOSIS)
GRADE 1 STEATOSISGRADE 2 STEATOSISGRADE 3 STEATOSISINVENTORY
Inflammation Grade*Fibrosis Score*NAFLD
Score**
Inflammation Grade*Fibrosis Score*NAFLD
Score**
Inflammation Grade*Fibrosis Score*NAFLD
Score**
Inflammation Grade*Fibrosis Score*NAFLD
Score**
HL160016Near normal0.66 / MMuscular Dystrophy000FFPE, SFT, SC, LEC
HL160018Near normal35 / FNone000FFPE, SFT
HL150002Near normal,
regeneration
24 / MNone0-100FFPE, SFT, SC
HL160026Near normal25 / FPulmonary Arterial Hypertension Lung Transplant000FFPE, SFT, HC P , SC, LEC
HL160033Near normal22 / MAcute Drug Toxicity, Metabolic acidosis000FFPE, SFT
HL170044Near Normal, minimal periportal inflammation47 / MAnoxia0-100FFPE, SFT, SC, KC, LEC, HC S
HL150004Near normal, ductal plate malformation54 / MNone110FFPE, SFT, SC, HC S
HL150006Near Normal, Vascular outflow defect31 / FSepsis (confirmed)100FFPE, SFT, SC
HL150008Near normal59 / MNone100-1FFPE, SFT, SC, HC P
HL150010Inflammmation (mild)69 / MDiabetes (Type 2), Hypertension, Renal Failure100FFPE, SFT, SC, HC S
HL160020Inflammation (mild,
chcronic)
43 / MNone100FFPE, SFT, SC, KC
HL160023Inflammation (mild, chronic), bile duct
hamartoma
57 / MDiabetes (Type 2) Hypertension100FFPE, SFT, SC
HL160034Inflammation (mild,
chcronic)
57 / F100FFPE, SFT, HC S , LEC, SC
HL160036Inflammation (mild)25 / MAcute Drug Toxicity0-100FFPE, SFT, SC,
HL160037Inflammation (mild, portal)47 / FHypertension100-1FFPE, SFT, HC S , SC, KC, LEC
HL160031Inflammation (mild), oxidative/toxic injury, fibrosis42 / MGERD120FFPE, SFT, HC P
HL160025Inflammation (mild), glycogen accumulation70 / MNone1-200FFPE, SFT, SC, HC P , KC, LEC
HL160019Inflammation (mild)53 / MNone1-200FFPE, SFT, SC, LEC
HL160028Inflammation
(granulomatous)
42 / MHypertension200FFPE, SFT
HL150001Steatosis47 / MDiabetes (Type 2)001FFPE, SFT, SC
HL160024Inflammation (chronic), Sepsis (possible), biliary
obstruction
62 / MDiabetes (Type 2), Hypertension, Gout201FFPE, SFT, SC, HC P , LEC
HL150009Steatosis, Drug-
induced injury
37 / MChronic drug exposure002FFPE, SFT, SC, HC S
HL160027Steatosis26 / MNone102FFPE, SFT, SC
HL160017Steatosis, cholangitis, fibrosis31 / MChronic Alcoholism, Hypertension122FFPE, SFT, SC, LEC
HL150013Steatosis, inflammation, fibrosis45 / MDiabetes (Type 2),

Hypertension
223FFPE, SFT, SC
HL160014Cirrhosis, steatosis, inflammation (chronic)60 / MChronic Alcoholism343FFPE, SFT, SC
HL160030Steatosis29 / MDiabetes (type 2), Hypertension, Asthma002FFPE, SFT, HC S
HL160032Inflammation (mild), Steatosis23 / MNone reported102FFPE, SFT, HC S , KC, LEC
HL160015Steatosis, fibrosis59 / MHypertension, Hyperlipidemia11a3FFPE, SFT, SC
HL160021Steatohepatitis (chronic, active), fibrosis44 / FDiabetes (Type 2), Chronic Kidney Disease11a4FFPE, SFT, SC, KC
HL160022Steatohepatitis (chronic, active),
fibrosis
45 / FEpilepsy125FFPE, SFT
HL160041Steatohepatitis, fibrosis, ascending cholangitis, possible drug injury33 / MNone reported226FFPE, SFT, KC, LEC, SC
Samsara hepatocytes are available through QPS Hepatic Bio.

hRPTEC inventory table

SAMPLE ID
DONOR
AGE / GENDER
DONOR
ETHNICITY
DONOR MORBIDITIESAVAILABLE INVENTORY
cryopreserved cells
HK160001RPTEC63 / MCaucasian
Diabetes (Type 2), hypertension,
coronary artery disease
p0 (34 vials)
HK160002RPTEC
45 / M
Caucasian
Benign CNS tumorp0 (105 vials)
HK160003RPTEC
56 / M
African American
Hypertension,
Chronic alcohol use,
Chronic cocaine use
p0 (86 vials)
HK160004RPTEC
62 / F
African American
Diabetes (type 2),
hypertension
p0 (38 vials)
HK160006RPTEC57 / FAfrican AmericanSarcoidosis,
hypertension,
rheumatoid arthritis,
hydrocephalus
p0 (68 vials)
p1 (70 vials)
HK160007RPTEC40 / M
African American
Hypertension
p0 (400 vials)